demonstrated that piR-hsa-54265 is an oncogenic RNA in the development of colorectal cancer (CRC) and a valuable biomarker better than other serum tumor markers routinely used in clinic, which would decrease dramatically after surgical resection of CRC but increase again when tumor relapses (41). This evidence concerns the gene PIR and neoplasm.